PharmaCielo Ltd.
PCLOF
$0.06
$0.0114.73%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 292.20K | -1.01M | -940.30K | -1.07M | -1.94M |
| Total Depreciation and Amortization | 314.30K | 61.80K | 14.50K | 206.30K | -20.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 164.30K | 861.00K | 926.90K | 719.00K | 1.56M |
| Change in Net Operating Assets | -390.10K | -2.48M | 1.53M | 10.80K | -5.30K |
| Cash from Operations | 380.70K | -2.56M | 1.53M | -137.30K | -405.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -540.40K | 5.38M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -540.40K | 5.38M | -- | -- | 0.00 |
| Total Debt Issued | 150.00K | 25.00K | 125.00K | 518.00K | 0.00 |
| Total Debt Repaid | 102.00K | -3.67M | -2.29M | -199.30K | -68.20K |
| Issuance of Common Stock | -- | -- | -- | -- | 607.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 180.80K | -2.65M | -1.56M | 227.70K | 395.10K |
| Foreign Exchange rate Adjustments | 2.40K | 10.10K | -1.50K | -2.70K | -500.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.40K | 181.50K | -34.40K | 87.60K | -10.50K |